You are viewing a feed that contains frequently updated content. When you subscribe to a feed, it is added to the Common Feed List. Updated information from the feed is automatically downloaded to your computer and can be viewed in Internet Explorer and other programs. http://bethesdatrials.cancer.gov/ http://blogs.law.harvard.edu/tech/rss Thu, 23 Sep 2010 11:22:46 -0400 Thu, 16 Sep 2010 17:38:41 -0400 FeedForAll v2.0 (2.0.2.9) http://www.feedforall.com "2009 Clinical Trials at NCI" feed will no longer be available as of September 30, 2010 http://bethesdatrials.cancer.gov/rss/default.aspx D191EE9F-B7A9-42C5-B54D-34D5A256DAC7 Thu, 16 Sep 2010 17:33:39 -0400 Information about 2010 clinical trials at NCI. http://bethesdatrials.cancer.gov/rss/default.aspx 9C8459F2-4F6E-48F6-BED3-5133D8CC5232 Thu, 1 Jul 2010 13:24:22 -0400 A Phase I Study of ABT-888, An Oral Inhibitor of Poly(ADP-ribose)Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0243 F6E6CD2B-D11A-4F65-A6B8-45E66E1A2940 Tue, 29 Dec 2009 10:35:15 -0500 A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0214 575238D9-0F34-49D0-ABD9-C460C112A603 Tue, 29 Dec 2009 10:34:37 -0500 Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0224 531062A3-09A1-4F13-8A5D-F5EBDC3FC597 Thu, 10 Dec 2009 10:29:41 -0500 A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0222 D647EEDB-1FC2-43C6-AB4A-4A9F1DF93889 Thu, 10 Dec 2009 10:29:03 -0500 Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0210 EFE0FBD1-64C8-4ADD-9080-575E0B7AA52D Mon, 19 Oct 2009 12:14:35 -0400 Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0212 8F931835-A5B6-48FB-84EF-FD4DE7902B10 Fri, 2 Oct 2009 09:26:08 -0400 A Phase II Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer, (mCRPC) http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0195 66E5C0C2-CB72-4A4C-9251-E51D4DCABCCE Fri, 2 Oct 2009 09:24:45 -0400 Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0192 19EA4BD5-26C4-486A-9753-B2D0B79932F9 Fri, 2 Oct 2009 09:23:44 -0400 Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0189 217716C7-3476-4230-A226-EFD1814C4ED4 Fri, 2 Oct 2009 09:20:58 -0400 A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase 2.5 Study of AZD0530, a Selective Src Kinase Inhibitor, In Patients With Recurrent Osteosarcoma Localized to the Lung (A Sarcoma Alliance for Research Through Collaboration [SARC] Study) http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0104 20DE4117-3EAE-453F-99E8-647355712855 Fri, 2 Oct 2009 09:20:36 -0400 A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0173 36429645-FD43-44B2-8716-C43DC6512B71 Fri, 14 Aug 2009 14:12:06 -0400 A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0139 75B8B736-493E-433D-952D-5516B7C79AEF Fri, 14 Aug 2009 14:10:33 -0400 A Phase I, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects With Refractory Solid Tumors Associated With EphA2 Expression http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0168 C4EC1D4C-7F16-49E3-BACB-90C334383693 Mon, 3 Aug 2009 10:06:45 -0400 A Phase I, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612) in Advanced Malignancies http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0111 47A21BD4-65F7-4F1D-AB8E-FCF032B18485 Mon, 3 Aug 2009 10:05:02 -0400 Phase I/II Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0092 42A92982-DFCB-4030-88B2-92A544CEE5B1 Mon, 3 Aug 2009 10:03:46 -0400 A Targeted Phase I Trial of ZD6474 (Vandetanib; ZACTIMA®) Plus the Proteasome Inhibitor Bortezomib (Velcade®) in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0089 91AF5BD1-76C4-4C95-B108-4EDA1BD083BC Mon, 3 Aug 2009 10:01:56 -0400 A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0138 4D816654-CD8C-43AF-A052-358B02A218B0 Tue, 16 Jun 2009 10:15:16 -0400 Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0103 740EBEB6-01BD-4F4B-887F-C3A9AD798EAC Tue, 16 Jun 2009 10:13:45 -0400 Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMac http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0096 5318A7C7-7210-4D05-B505-C0A647BED431 Tue, 16 Jun 2009 10:12:30 -0400 Phase I/II Study of B-Cell Malignancies Using T Cells Expressing an Anti-DC19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prior to T-Cell Transfer http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0082 F934D5CC-9C28-47AF-A10B-49E9022F44AE Tue, 16 Jun 2009 10:11:00 -0400 Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi's Sarcoma http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0130 5CF95389-5808-4334-9E8C-E0A1DA443D26 Mon, 8 Jun 2009 12:19:05 -0400 Phase II Study of Neoadjuvant Gemcitabine, Cisplatin, and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer http://bethesdatrials.cancer.gov/clinical-research/faq.aspx?ProtocolID=NCI-09-c-0107 33303B68-9349-4510-AA62-2D830D59EA47 Tue, 28 Apr 2009 09:15:04 -0400 An Open-Label Phase I Study to Evaluate the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-Expressing Carcinoma http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0101 F056C935-25B0-454A-8841-20E68010226E Tue, 28 Apr 2009 09:13:42 -0400 A Natural History Study of Patients Receiving High Dose Rate Brachytherapy http://bethesdatrials.cancer.gov/clinical-research/faq.aspx?ProtocolID=NCI-09-C-0100 FD766417-A1F9-48D2-B9D0-E1A03ED17CC2 Tue, 5 May 2009 10:34:00 -0400 The Natural History of Solid Organ Cancer Stem Cells http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0079 4B95BFA3-160B-48C9-AB00-EB5C55B09F36 Tue, 5 May 2009 10:33:24 -0400 An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma http://bethesdatrials.cancer.gov/clinical-research/faq.aspx?ProtocolID=NCI-09-C-0077 4B4BA2D7-3E0E-40B6-9F1C-EB120C3DE8BB Tue, 28 Apr 2009 09:12:49 -0400 Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia (HCL) http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0076 DF1B5667-F7E1-43A0-A088-76EA2498B720 Tue, 28 Apr 2009 09:11:29 -0400 Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin http://bethesdatrials.cancer.gov/clinical-research/faq.aspx?ProtocolID=NCI-09-C-0072 2F8F9F2A-64A9-46B4-BF5F-38CC5CF05335 Tue, 28 Apr 2009 09:10:26 -0400 Phase I Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T- and NK-Cell Lymphomas http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0065 AB296DFF-C468-4064-8E81-4EFE760C3DD2 Tue, 28 Apr 2009 09:09:32 -0400 A Phase II Study of Bevacizumab in Combination With Ixabepilone in Subjects With Advanced Renal Cell Carcinoma http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0057 BBA3BAA1-6789-429E-8E7B-DD1FF1821313 Tue, 28 Apr 2009 09:07:29 -0400 Phase II Study of Metastatic Melanoma Using a Chemoradiation Lymphodepleting Conditioning Regimen Followed by Infusion of Anti-Mart-1 and Anti-gp100 TCR-Gene Engineered Lymphocytes and Peptide Vaccines http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0051 CC5D21F1-19E5-439D-9E42-D5DCA4130A95 Tue, 28 Apr 2009 09:07:28 -0400 A Phase I Study of ABT-888 in Combination With Metronomic Cyclophosphamide in Adults With Refractory Solid Tumors and Lymphomas http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0048 767128FB-9099-40B6-93B5-1B284E92600F Tue, 28 Apr 2009 09:05:11 -0400 Phase II Study of Metastatic Cancer that Expresses Carcinoembryonic Antigen (CEA) Using Lymphodepleting Conditioning Followed by Infusion of Anti-CEA TCR-Gene Engineered Lymphocytes http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0047 4CB39989-E652-476B-9311-90446114CD69 Tue, 28 Apr 2009 09:04:29 -0400 A Phase II Clinical Trial of Ixabepilone (Ixempra, BMS-247550, NSC 710428), an Epothilone B Analog, in Cervical Cancer http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0037 D131CBC2-60AF-4BB5-9F61-4A2705B622D3 Tue, 28 Apr 2009 08:56:57 -0400 Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0025 69226F73-6250-4E88-8537-869B37DDF5A1 Tue, 28 Apr 2009 08:53:06 -0400 A Phase I Study of Dasatinib in Combination With Bevacizumab in Advanced Solid Tumors http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0019 148D9AF1-5872-483F-9F5C-DD4855A862DC Tue, 28 Apr 2009 08:53:03 -0400 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Adults With Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Two or More Prior Treatment Regimens http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0018 BB7580FC-8F96-4FE5-9C98-7C00428878EF Tue, 28 Apr 2009 08:48:55 -0400 Randomized Trial of Cladribine (CdA) With Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0005 0DC785D3-F239-4F03-B62D-F74BB205E3B7 Tue, 28 Apr 2009 08:45:09 -0400 A Phase I and Pharmacokinetic Single-Agent Study of Pazopanib in Adults With Advanced Malignancies and Varying Degrees of Liver Dysfunction http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-09-C-0003 6CBD4A8A-DC27-40CB-BCB2-13D3E70BFE48 Tue, 28 Apr 2009 08:45:05 -0400